Pancreatic Cancer Therapeutics and Diagnostic Market
According to Intent Market Research, the Pancreatic Cancer Therapeutics and Diagnostic Market is expected to grow from USD 3.7 Billion in 2024-e at a CAGR of 10.4% to touch USD 6.8 Billion by 2030. The Pancreatic Cancer Therapeutics and Diagnostic Market is dominated by key players such as, Roche, Novartis, Bristol-Myers Squibb, Merck & Co., Sanofi, and AbbVie.